web analytics
18.3 C
Munich
Friday, May 20, 2022
type here...

CATEGORY

BioPharma

BioPharma

Enzolytics Inc (OTCMKTS: ENZC) Powerful Reversal Underway as Immune™ Goes International in Booming Nutritional Supplement Market

Boe Rimes -
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time...
BioPharma

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Coming Back After Major Short Attack While Biotech Reports Primary and Secondary Endpoints Met for DCVax®-L with Excellent Safety...

Boe Rimes -
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is moving northbound once again after a major short attack with at least 15 million shares sold short decimated...
BioPharma

Stratos Renewables Corp (OTCMKTS: SRNW) Bull Runner, Trifecta & The Perfect Merger

Boe Rimes -
Stratos Renewables Corp (OTCMKTS: SRNW) is among the most exciting stocks in penny stocks already seeing a historic rise from sub pennies last year...
BioPharma

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Bull Run as Biotech Set to Release Phase III Top Line Data for DCVax®-L May 10 / Dr. Linda...

Boe Rimes -
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is tearing up the charts making a powerful run northbound easily eclipsing the $1.50 mark where the stock had...
BioPharma

Pacific Ventures Group Inc (OTCMKTS: PACV) Heating Up and Moving Northbound After Foods Wholesale and Distribution Innovator Reports Record $42 Million in 2021 Revenues

Boe Rimes -
Pacific Ventures Group Inc (OTCMKTS: PACV) is up big reversing off $0.0153 lows after many months of decline which included a 1:500 reverse stock...
BioPharma

VirExit Technologies Inc (OTCMKTS: VXIT) Heating Up and Getting Noticed as PPE Innovator’s BreatheEasyMask Using LIVINGUARD® Patented Technology Gains Traction

Boe Rimes -
VirExit Technologies Inc (OTCMKTS: VXIT) is an exciting sub penny stock that ran to $0.12 in early 2021 that is now bottomed out at...
123...23Page 1 of 23

Latest news

© All rights reserved.

About Us

Popular Category

Editor Picks